Key result
Telemedical care linked to ~47% higher 1-year survival odds vs matched controls in CHF.
Why the study?
The utility of telemedical care and monitoring programs for chronic heart failure patients in routine care settings remains unclear.
Does a telemedical care and monitoring program improve survival in patients with chronic heart failure?
Cohort (n=5,662)
Does a telemedical care and monitoring program improve survival in patients with chronic heart failure?
Odds Ratio: 1.47 (95% CI 1.21–1.8)
p-value: p=< .001
Telemedical care and monitoring programs in routine care significantly improve 1- and 2-year survival in patients with chronic heart failure.
Telemedical monitoring was associated with higher survival in chronic HF; hypothesis-generating and should not yet change practice pending RCTs.
BACKGROUND: Telemedical care and monitoring programs for patients with chronic heart failure have shown beneficial effects on survival in several small studies. The utility in routine care remains unclear. METHODS: We evaluated a large-sized telemedicine program in a routine care setting, enrolling in total 2,622 patients (54.7 percent male, mean age: 73.7 years) with chronic heart failure. We used reimbursement data from a large statutory health insurance and approached a matched control analysis. In a complex propensity score matching procedure, 3,719 suitable controls (54.2 percent male, mean age: 74.5 years) were matched to 1,943 intervention patients (54.1 percent male, mean age: 74.4 years). The primary endpoint of our analysis was survival after 1 year. RESULTS: Analyses revealed a higher survival probability among subjects of the intervention group compared to controls group after 1 year (adjusted OR: 1.47, CI 95 percent: 1.21-1.80, p < .001) and 2 years (adjusted OR: 1.51, CI 95 percent: 1.28-1.77, p < .001), respectively. CONCLUSIONS: The probabilities to survive after 1 and 2 years were significantly increased in the intervention group. Our findings confirm previous results of controlled trials and importantly indicate that patients with chronic heart failure may benefit from telemonitoring programs in routine care.
No takes yet. Share an insight, caveat, or question.
Herold et al. (2017) conducted a cohort in chronic heart failure (n=5,662). Telemedical care and monitoring vs. Matched controls was evaluated on survival after 1 year (OR 1.47, 95% CI 1.21-1.80, p=< .001). Telemedical care and monitoring significantly increased 1-year survival in patients with chronic heart failure compared to matched controls (OR 1.47; 95% CI 1.21-1.80; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: